$12MSeries A, 14 October 2025
Funds manufacturing scale-up and early commercialization ahead of first approval in Brazil.
- Amount
- $12M
- Stage
- Series A
- Announced
- 14 October 2025
- Lead
- Acre Venture Partners
- Other investors
- Corteva Catalyst, Syngenta Group Ventures, Trailhead Capital, The Yield Lab
- Use of funds
- Funds manufacturing scale-up and early commercialization ahead of first approval in Brazil.
- Checked
- Announced by the company
- Sources
- Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by businesswire.com
Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by news.google.com